ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
다우존스 지수
39,069.59
0.01%
Bitcoin
69,459.44
1.38%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Scinai Immunotherapeutics Ltd (SCNI)

  7. Scinai Immunotherapeutics Ltd (SCNI) 뉴스

SCNI Scinai Immunotherapeutics Ltd

3.62
-0.0613 (-1.67%)
25 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Scinai Immunotherapeutics Ltd SCNI 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.0613 -1.67% 3.62 13:00:08
개장가 저가 고가 종가 전일 종가
3.99 3.70 4.40 4.14 3.6813
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/05/202405:01PRNUSScinai Immunotherapeutics Announces Receipt of a Nasdaq..
17/05/202402:49EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/05/202406:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/05/202405:01PRNUSScinai Publishes FY 2023 Financial Statements, Files Annual..
07/05/202423:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/05/202422:21PRNUSScinai Immunotherapeutics Announces Receipt of Nasdaq..
10/04/202420:00PRNUSScinai to showcase its novel biological local therapeutic..
09/04/202406:15APSBiotech Rips Following Five-Year Master Service Agreement..
08/04/202420:00PRNUSScinai Immunotherapeutics' CDMO Unit Selected by Ayana..
12/03/202421:00PRNUSScinai leadership to attend BIO-Europe Spring 2024
29/02/202422:45PRNUSScinai to showcase its cGMP biologics CDMO and innovative..
13/02/202421:00PRNUSScinai Welcomes Liat Halpert as Head of Business Development..
31/01/202406:19EDGAR2Form F-3 - Registration statement by foreign private issuers
26/01/202400:26PRNUSScinai Immunotherapeutics Congratulates its Co-Lead..
25/01/202404:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/01/202401:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/01/202421:32EDGAR2Form D - Notice of Exempt Offering of Securities
09/01/202422:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/01/202406:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/01/202406:01PRNUSScinai Immunotherapeutics Announces Closing of Exercise of..
04/01/202420:15PRNUSScinai Immunotherapeutics CEO Issues Letter to Shareholders
02/01/202423:58EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/01/202423:57EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/01/202423:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/01/202423:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/01/202422:24EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/12/202323:21PRNUSScinai Immunotherapeutics Announces Exercise of Outstanding..
27/12/202321:15PRNUSScinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar..
22/12/202323:11EDGAR2Form F-1/A - Registration statement for certain foreign..
14/12/202320:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202321:26PRNUSScinai Announces Promising Results in a Psoriatic Human Skin..
11/12/202322:11PRNUSStudy published in Antiviral Research supports promise of..
29/11/202323:25PRNUSEuropean Investment Bank (EIB) extends maturity of its..
21/11/202300:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202321:30PRNUSScinai Immunotherapeutics Regains Compliance with Nasdaq's..
13/11/202322:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202320:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202321:30GLOBEScinai Immunotherapeutics Announces Award of Non-Dilutive..
04/11/202305:30GLOBEScinai Immunotherapeutics Provides Update Regarding Nasdaq..
03/11/202321:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202302:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202322:00GLOBEEuropean Investment Bank (EIB) considering extending..
31/10/202321:23GLOBEScinai Reports Third Quarter 2023 Financial Results and..
31/10/202305:59EDGAR2Form F-1 - Registration statement for certain foreign..
30/10/202320:00GLOBEScinai Immunotherapeutics to Attend BIO-Europe Munich 2023
04/10/202320:30GLOBEScinai Immunotherapeutics to Showcase its end-to-end cGMP..
23/09/202305:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/09/202319:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/09/202305:05GLOBEScinai Immunotherapeutics Announces Closing of $1.33 Million..
20/09/202304:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

최근 히스토리

NASDAQ
SCNI
Scinai Immunotherapeutics
NASDAQ
SHQAW
Shelter Acquisition Corp...
EU
3SPA
Graniteshares 3x Short P...
NASDAQ
GDLXV
BIT
F14609
Vontobel Financial Produ...
BIT
UB3RW8
Unicredit Bank
GATE
SPELLFIREUSDT
SPELLFIRE Token
NASDAQ
SLAMU
Slam
BOV
EMBR3F
EMBRAER ON
BIT
1VFC
VF
BOV
MGLUR170
MGLUR170 Ex:1,69
COIN
SLOTHUSD
NASDAQ
LTRWY
Lottery com
AMEX
EMHC
Spdr Bloomberg Barclays ...
ASX
RIOIOB
COIN
BBCCEUR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유